Status:
COMPLETED
PET/MRI in the Diagnosis of Pediatric Chronic Pain
Lead Sponsor:
Stanford University
Collaborating Sponsors:
GE Healthcare
Conditions:
Chronic Pain
Pediatric Disorder
Eligibility:
All Genders
11-18 years
Phase:
PHASE1
Brief Summary
\[18F\]FTC-146 is a sigma-1 receptor detector and is an experimental radiotracer. Several studies have implicated involvement of sigma-1 receptors in generation and perpetuation of chronic pain condit...
Detailed Description
It is estimated that 20% to 35% of children and adolescents worldwide are affected by chronic pain. As a result of chronic pain, children may miss school, withdraw from social activities, and develop ...
Eligibility Criteria
Inclusion
- 11-18 years old.
- Chronic pain (nociceptive, neuropathic or mixed pain) lasting at least 2 months.
- Pain level of at least 4/10 on a 0-10 Comparative Pain Scale (reported at time of screening).
- Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative test result from the Covid test within 72 hours of the scan.
Exclusion
- MRI incompatible
- Pregnant or nursing
- Non-English speaker
- Claustrophobic
Key Trial Info
Start Date :
November 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04435821
Start Date
November 19 2020
End Date
October 31 2024
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305